NEW YORK (GenomeWeb News) – Theranostics Health said today that it is collaborating with Duke University on a research effort for new prevention and treatment options for breast cancer under a recent grant from the Susan G. Komen Foundation.

The Rockville, Md.-based firm said that it has been collaborating with Duke investigator Victoria Seewaldt for the past year. That research formed the "underlying rationale and preliminary data in support of the research proposed" to the Komen Foundation, which is now providing Duke with a Promise Grant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.